Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors

Scheuplein F, Renner F, Campbell JE, … Bischoff JR · Front Immunol 2024 · Front Immunol 15:1411395

STK17B Ser/Thr kinase Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens